HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.

AbstractOBJECTIVE:
We prospectively screened a large European cohort of patients presenting with hyperCKemia and/or limb-girdle muscular weakness (LGMW) for acid α-glucosidase (GAA) deficiency by dried blood spot (DBS) investigation.
METHODS:
DBS were collected from 3,076 consecutive adult patients from 7 German and British neuromuscular centers. All specimens were investigated for GAA deficiency by fluorometry. Samples with reduced enzyme activity were subsequently investigated for GAA gene mutations.
RESULTS:
Of 3,076 patients with DBS samples, 232 patients (7.6%) showed low GAA enzyme activity. Of these 232 patients, 55 (24%) presented with isolated hyperCKemia and 176 (76%) with hyperCKemia and LGMW. With both features present, 94% of the patients showed a low enzymatic activity. Mutational analysis found GAA gene mutations in 74 patients (2.4%); herein 70 patients were heterozygote for the common GAA gene splice-site mutation c.-32-13T>G. The most common clinical presentation in the confirmed Pompe cohort was a limb-girdle phenotype (85.3%) combined with ventilatory insufficiency (61%). Isolated hyperCKemia was found in 12%, while 2.7 had hyperCKemia and ventilatory insufficiency only.
CONCLUSIONS:
In a large cohort of unselected adult patients with hyperCKemia and/or LGMW, we found a prevalence of late-onset Pompe disease of 2.4%. Therefore, targeted screening of such a population should be encouraged in clinical practice.
AuthorsZoltan Lukacs, Paulina Nieves Cobos, Stephan Wenninger, Tracey A Willis, Michela Guglieri, Marc Roberts, Rosaline Quinlivan, David Hilton-Jones, Teresinha Evangelista, Stephan Zierz, Beate Schlotter-Weigel, Maggie C Walter, Peter Reilich, Thomas Klopstock, Marcus Deschauer, Volker Straub, Wolfgang Müller-Felber, Benedikt Schoser
JournalNeurology (Neurology) Vol. 87 Issue 3 Pg. 295-8 (Jul 19 2016) ISSN: 1526-632X [Electronic] United States
PMID27170567 (Publication Type: Journal Article, Multicenter Study)
Copyright© 2016 American Academy of Neurology.
Chemical References
  • Creatine Kinase
  • alpha-Glucosidases
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Creatine Kinase (blood)
  • Dried Blood Spot Testing
  • Female
  • Germany (epidemiology)
  • Glycogen Storage Disease Type II (blood, complications, epidemiology, genetics)
  • Humans
  • Male
  • Middle Aged
  • Muscular Dystrophies, Limb-Girdle (complications, enzymology, epidemiology, genetics)
  • Mutation
  • Phenotype
  • Prevalence
  • United Kingdom (epidemiology)
  • Young Adult
  • alpha-Glucosidases (blood, deficiency, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: